Pyridine

Pyridine

SCHEMBL294375

NNC(=O)O.c1ccncc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 2/20 0.50
TSHR P16473 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MPO P05164 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CYP2A6 P11509 1/20 0.44
P2RX7 Q99572 5/20 0.41
CYP2C9 P11712 2/20 0.39
ALDH1A1 P00352 3/20 0.37
PLOD2 O00469 2/20 0.37
TAAR1 Q96RJ0 1/20 0.37
PLOD3 O60568 1/20 0.37
HPGD P15428 1/20 0.37
PLOD1 Q02809 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL4655282 0.86 TDP1 (0.47) NAPRTTSHRTDP1CYP1A2CYP3A4
Pyridine SCHEMBL27474885 0.86 CYP1A2 (0.53) NAPRTTSHRTDP1CYP1A2CYP3A4
Pyridine SCHEMBL10974779 0.84 NAPRT (0.45) NAPRTTSHRTDP1CYP1A2CYP3A4
Pyridazine SCHEMBL27711578 0.83 P2RX7 (0.43) NAPRTTSHRCYP1A2CYP3A4CYP2D6
Pyridine SCHEMBL10980010 0.82 NAPRT (0.43) NAPRTTSHRTDP1CYP1A2CYP3A4
Benzene SCHEMBL28076350 0.82 CYP1A2 (0.47) TSHRTDP1CYP1A2CYP3A4CYP2D6
Pyridine SCHEMBL7904912 0.80 NAPRT (0.53) NAPRTTSHRTDP1CYP1A2CYP3A4
Pyridine SCHEMBL9065525 0.79 NAPRT (0.60) NAPRTTSHRTDP1CYP1A2CYP3A4
Pyridine SCHEMBL1164077 0.79 NAPRT (0.60) NAPRTTSHRTDP1CYP1A2CYP3A4
Pyridine SCHEMBL1070164 0.79 NAPRT (0.60) NAPRTTSHRTDP1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110483423-A P2X4 receptor antagonist NIPPON CHEMIPHAR CO 2019-11-22 CN disclosed
CN-104350055-B Bicyclic heteroaryl derivatives and application thereof as MNK1 and MNK2 regulator 新加坡科技研究局 2019-05-31 CN disclosed
CN-109689649-A BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS 百时美施贵宝公司 2019-04-26 CN disclosed
CN-108863959-A P2X4 RECEPTOR ANTAGONIST 日本化学药品株式会社 2018-11-23 CN disclosed
CN-103635467-B Oxaziza compounds as ion channel modulators 吉利德科学公司 2017-08-04 CN disclosed
CN-101454320-B Pyridine[3,4-b]pyrazinones PFIZER PROD INC 2012-12-19 CN disclosed
EP-2235092-B1 COATED POLYOXYMETHYLENES BASF SE (DE) 2012-03-14 EP disclosed
CN-102256964-A Compuestos inhibidores de quinasa map p38 RESPIVERT LTD 2011-11-23 CN disclosed
EP-2235092-A1 COATED POLYOXYMETHYLENES BASF SE (DE) 2010-10-06 EP disclosed
WO-2009092698-A1 COATED POLYOXYMETHYLENES BASF SE (DE) 2009-07-30 WO disclosed
CN-101400678-A Thiophene amides useful as protein kinase inhibitors VERTEX PHARMA (US) 2009-04-01 CN disclosed
CN-101384586-A PI-3 kinase inhibitors and methods of use thereof NOVARTIS AG (CH) 2009-03-11 CN disclosed
CN-101137376-A Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use MERCK & CO INC (US) 2008-03-05 CN disclosed
CN-1130365-C Alpha-1 adrenergic compounds, pharmaceutical compositions containing the same and uses thereof ABBOTT CO (US) 2003-12-10 CN disclosed
CN-1246861-A Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds ABBOTT LAB (US) 2000-03-08 CN disclosed
EP-0159962-B1 FIBRE-REACTIVE CHROMIUM OR COBALT COMPLEXES, THEIR PREPARATION AND THEIR USE CIBA-GEIGY AG (CH) 1989-02-08 EP disclosed
EP-0159962-A2 Fibre-reactive chromium or cobalt complexes, their preparation and their use CIBA-GEIGY AG (CH) 1985-10-30 EP disclosed